Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ - Prostaglandin E2 dependent proliferation of growth plate chondrocytes

Arthritis Research and Therapy

Volumn 8, Issue 3, 2006, Pages

  Brochhausen, Christoph ^a   Neuland, Pia ^b   Kirkpatrick, C James ^a   Nüsing, Rolf M ^c   Klaus, Günter ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2; FOLATE RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN SYNTHASE;

ANIMAL; CARTILAGE CELL; CELL DIVISION; CYTOLOGY; DISEASE MODEL; GROWTH PLATE; MACROPHAGE; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; CARRIER PROTEINS; CELL DIVISION; CHONDROCYTES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; FOLATE RECEPTORS, GPI-ANCHORED; GROWTH PLATE; MACROPHAGES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, PROSTAGLANDIN E;

EID: 70350523833     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1948     Document Type: Article

References (46)

1. Klein DC, RaiSz LG: Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970, 86:1436-1440.
2. Flanagan AM, Chambers TJ: Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology 1992, 130:443-448.
3. Weinreb M, Rutledge SJ, Rodan GA: Systemic administration of an anabolic dose of prostaglandin E(2) induces earlyresponse genes in rat bones. Bone 1997, 20:347-353.
4. Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H: Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 1994, 50:169-172.
5. Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, Hahn TJ: Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: Role of second messengers. Endocrinology 1996, 137:2208-2216.
6. Schwartz Z, Gilley RM, Sylvia VL, Dean DD, Boyan BD: The effect of prostaglandin E2 on costochondral chondrocyte differentiation is mediated by cyclic adenosine 3',5'-monophosphate and protein kinase C Endocrinology 1998, 139:1825-1834.
7. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN: Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes J Bone Miner Res 1992, 7:397-404.
8. Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Iwaya T: Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 1980, 97:834-836.
9. Suponitzky I, Weinreb M: Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae. J Endocrinol 1998, 156:51-57.
10. Marks SC Jr, Miller S: Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo. J Oral Pathol 1988, 17 500-505.
11. Yang RS, Liu TK, Lin-Shiau SY: Increased bone growth by local prostaglandin E2 in rats. Calcif Tissue Int 1993, 52 57-61.
12. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998, 38:97-120.
13. Sylvia VL, Del Toro F, Dean DD, Hardin RR, Schwartz Z, Boyan BD: Effects of 1alpha,25-(OH)(2)D(3) on rat growth zone chondrocytes are mediated via cyclooxygenase-1 and phospholipase A(2). J Cell Biochem 2001, 81:32-45.
14. Simon AM, Manigrasso MB, O'Connor JP: Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002, 17:963-976.
15. Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H: Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: Abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors. J Bone Miner Res 2001, 16:1272-1280.
16. Abulencia JP, Gaspard R, Healy ZR, Gaarde WA, Quackenbush J, Konstantopoulos K: Shear-induced cyclooxygenase-2 via a JNK2/ c-Jun-dependent pathway regulates prostaglandin receptor expression in chondrocytic cells. J Biol Chem 2003, 278:28388-28394.
17. Siegle I, Klein T, Backman JT, Saal JG, Nüsing RM, Fritz P: Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998, 41:122-129.
18. Narumiya S, SugimotS Y, Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
19. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M, et al.: Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 2002, 99:4580-4585.
20. Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T: Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 2003, 11 644-652.
21. Klaus G, von Eichel B, May T, Hügel U, Mayer H, Ritz E, Mehls O: Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells. Endocrinology 1994, 135:1307-1315.
22. Erdmann S, Müller W, Bahrami S, Vornehm SI, Mayer H, Bruckner P, von der Mark K, Burkhardt H: Differential effects of parathyroid hormone fragments on collagen gene expression in chondrocytes. J Cell Biol 1996, 135:1179-1191.
23. Kömhoff M, Gröne HJ, Klein T, Seyberth HW, Nüsing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997, 272 F460-468.
24. Morath R, Klein T, Seyberth HW, Nüsing RM: Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 1999, 10:1851-1860.
25. Kawamori T, Uchiya N, Kitamura T, Ohuchida S, Yamamoto H, Maruyama T, Sugimura T, Wakabayashi K: Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis Anticancer Res 2001, 21:3865-3869.
26. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S: Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997, 122:217-224.
27. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T: The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology 2000, 141:1554-1559.
28. Benya PD, Shaffer JD: Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982, 30:215-224.
29. Bohme K, Conscience-Egli M, Tschan T, Winterhalter KH, Bruckner P: Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: The role of insulin-like growth factor-I, insulin, or thyroxine J Cell Biol 1992, 116:1035-1042.
30. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229.
31. Bittinger F, Brochhausen C, Kohler H, Lehr HA, Otto M, Skarke C, Walgenbach S, Kirkpatrick CJ: Differential expression of cell adhesion molecules in inflamed appendix: Correlation with clinical stage J Pathol 1998, 186:422-428.
32. Schweer H, Watzer B, Seyberth HW: Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr 1994, 652:221-227.
33. Balmain N, von Eichel B, Toury R, Belquasmi F, Hauchecorne M, Klaus G, Mehls O, Ritz E: Calbindin-D28K and -D9K and 1,25(OH)2 vitamin D3 receptor immunolocalization and mineralization induction in long-term primary cultures of rat epiphyseal chondrocytes. Bone 1995, 17:37-45.
34. O'Keefe RJ, Puzas JE, Loveys L, Hicks DG, Rosier RN: Analysis of type II and type X collagen synthesis in cultured growth plate chondrocytes by in situ hybridization: Rapid induction of type X collagen in culture J Bone Miner Res 1994, 9:1713-1722.
35. Fukunaga T, Yamashiro T, Oya S, Takeshita N, Takigawa M, Takano-Yamamoto T: Connective tissue growth factor mRNA expression pattern in cartilages is associated with their type I collagen expression. Bone 2003, 33:911-918.
36. Schweer H, Kammer J, Kühl PG, Seyberth HW: Determination of peripheral plasma prostanoid concentration: An unreliable index of "in vivo" prostanoid activity. Eur J Clin Pharmacol 1986, 31:303-305.
37. Chowdhury TT, Bader DL, Lee DA: Dynamic compression counteracts IL-1 beta-induced release of nitric oxide and PGE2 by superficial zone chondrocytes cultured in agarose constructs. Osteoarthritis Cartilage 2003, 11:688-696.
38. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, Ito S, Narumiya S, Ichikawa A: Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 1993, 268:20175-20178.
39. Clark CA, Schwarz EM, Zhang X, Ziran NM, Drissi H, O'Keefe RJ, Zuscik MJ: Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun 2005, 328:764-776.
40. Funk CD, Furci L, FitzGerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters KM: Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 1993, 268:26767-26772.
41. Klaus G, König B, Hügel U, Ritz E, Mehls O: Intermittent and continuous exposure to 1,25(OH)2D3 have different effects on growth plate chondrocytes in vitro. Kidney Int 1993, 44:708-715.
42. Schwartz Z, Gilley RM, Sylvia VL, Dean DD, Boyan BD: Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner. Bone 1999, 24:475-484.
43. de Brum-Fernandes AJ, Morisset S, Bkaily G, Patry C: Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture. Br J Pharmacol 1996, 118:1597-1604.
44. Del Toro F Jr, Sylvia VL, Schubkegel SR, Campos R, Dean DD, Boyan BD, Schwartz Z: Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes. J Cell Physiol 2000, 182:196-208.
45. Aoyama T, Liang B, Okamoto T, Matsusaki T, Nishijo K, Ishibe T, Yasura K, Nagayama S, Nakayama T, Nakamura T, et al.: PGE2 signal through EP2 promotes the growth of articular chondrocytes. J Bone Miner Res 2005, 20:377-389.
46. Sylvia VL, Del Toro F Jr, Hardin RR, Dean DD, Boyan BD, Schwartz Z: Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 2001, 78:261-274.